Inhibiting hepatitis c virus processing and replication

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A01N 43/40 (2006.01) A01N 43/42 (2006.01) A61K 31/00 (2006.01) A61K 31/365 (2006.01) A61K 31/395 (2006.01) A61K 39/385 (2006.01)

Patent

CA 2416603

The present invention features methods for inhibiting HCV replication and processing by targeting heat shock protein 90 (HSP90). HSP90 is a cellular chaperone protein that was found to be an essential factor in NS2/3 self- cleavage. HSP90 can be targeted using compounds inhibiting the ability of HSP90 to facilitate NS2/3 cleavage.

L'invention concerne des procédés permettant d'inhiber la réplication et la maturation de HCV par ciblage d'une protéine de stress 90 (HSP90). HSP90 est une protéine chaperonne cellulaire dont on a découvert qu'elle constitue un facteur essentiel de l'auto-clivage de NS2/3. HSP90 peut être ciblée au moyen de composés inhibant la capacité de HSP90 à faciliter le clivage de NS2/3.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Inhibiting hepatitis c virus processing and replication does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibiting hepatitis c virus processing and replication, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibiting hepatitis c virus processing and replication will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1399726

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.